Previous Close | 1.7000 |
Open | 1.7700 |
Bid | 1.4400 x 1100 |
Ask | 1.4500 x 2200 |
Day's Range | 1.6950 - 2.0500 |
52 Week Range | 0.4900 - 2.0500 |
Volume | |
Avg. Volume | 2,566,988 |
Market Cap | 395.713M |
Beta (5Y Monthly) | 0.78 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2800 |
Earnings Date | May 06, 2024 - May 10, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4.33 |
Subscribe to Yahoo Finance Plus to view Fair Value for AKBA
It's been a pretty great week for Akebia Therapeutics, Inc. ( NASDAQ:AKBA ) shareholders, with its shares surging 16...
Akebia Therapeutics ( NASDAQ:AKBA ) Full Year 2023 Results Key Financial Results Revenue: US$194.6m (down 34% from FY...
Financial Highlights and Upcoming PDUFA Date for Vadadustat